Marrone Bio (MBII) Gets a Buy Rating from H.C. Wainwright

By Ryan Adsit

H.C. Wainwright analyst Amit Dayal maintained a Buy rating on Marrone Bio (MBIIResearch Report) today and set a price target of $2.50. The company’s shares closed on Friday at $1.30.

Dayal said:

“We have not yet incorporated the effect of the financing and the proposed acquisition in our model. If, and when, the transaction closes, we believe that the company’s revenues for 2019 should be expected to be higher, relative to our current expectation, by single-digit millions. Currently, we are projecting MBII to generate revenues of $30.3M in 2019. We expect revenues to reach $160.7M in 2025, growing at a six-year CAGR of 32.0%, relative to 2019 levels. We are estimating gross margin to stay at 55-56% level for the next several years.”

According to, Dayal is a 4-star analyst with an average return of 4.4% and a 44.2% success rate. Dayal covers the Industrial Goods sector, focusing on stocks such as Advanced Emissions Solutions, Inc., Ballard Power Systems, and Orion Energy Systems.

Currently, the analyst consensus on Marrone Bio is a Strong Buy with an average price target of $2.25, implying a 73.1% upside from current levels. In a report issued on August 9, Aegis Capital also maintained a Buy rating on the stock with a $2 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $2.14 and a one-year low of $1.10. Currently, Marrone Bio has an average volume of 131.7K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Marrone Bio Innovations, Inc. engages in the provision of bio-based pest management and plant health products for the agricultural and water treatment markets. Its brand includes regalia, bio-tam, grandevo, venerate and majestene. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Davis, CA.